Search

Displaying results 8381 - 8390 of 10000 in total
  1. Drug

    BMS-188797

    go.drugbank.com/drugs/DB12619
    Investigational

    BMS-188797 has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.

  2. Drug

    Aclerastide

    go.drugbank.com/drugs/DB12631
    Investigational

    Aclerastide has been investigated for the treatment of Diabetic Foot, Diabetic Foot Ulcers, and Foot Ulcer, Diabetic.

  3. Drug

    Ibipinabant

    go.drugbank.com/drugs/DB12649
    Investigational

    Ibipinabant has been used in trials studying the treatment of Obesity and Obesity and Type 2 Diabetes.

    Categories: Cannabinoid Receptor Antagonists, Receptor, Cannabinoid, CB1, antagonists & inhibitors
  4. Drug

    Methylselenocysteine

    go.drugbank.com/drugs/DB12697
    Investigational

    Methylselenocysteine has been used in trials studying the prevention of Prostate Carcinoma and No Evidence of Disease.

    Synonyms: SE-METHYL-SELENO-L-CYSTEINE
  5. Drug

    Omipalisib

    go.drugbank.com/drugs/DB12703
    Investigational

    Omipalisib has been used in trials studying the treatment of CANCER, Solid Tumours, and Idiopathic Pulmonary Fibrosis.

  6. Drug

    Bindarit

    go.drugbank.com/drugs/DB12739
    Investigational

    Bindarit has been used in trials studying the prevention and treatment of Coronary Restenosis and Diabetic Nephropathy.

  7. Drug

    DTP-348

    go.drugbank.com/drugs/DB12741
    Investigational

    Dtp348 has been used in trials studying the treatment of Solid Tumors and Head and Neck Neoplasms.

  8. Drug

    Albusomatropin

    go.drugbank.com/drugs/DB12950
    Investigational

    Albusomatropin has been used in trials studying the treatment of Growth Hormone-Deficiency and Growth Hormone Deficiency.

    Synonyms: HUMAN SERUM ALBUMIN FUSED TO THE N-TERMINUS OF GROWTH HORMONE
  9. Drug

    CHS-828

    go.drugbank.com/drugs/DB12980
    Investigational

    CHS-828 has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.

  10. Drug

    ST101 peptide

    go.drugbank.com/drugs/DB17272
    Experimental

    ST101 is a cell-penetrating peptide that disrupts the protein-protein interactions driving ATF5-regulated gene transcription.